Over the last 7 days, the United States market has risen by 2.0% and is up 12% over the past year, with earnings forecasted to grow by 14% annually. In such a dynamic environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and robust financial health to capitalize on these favorable conditions.

Top 10 High Growth Tech Companies In The United States

Click here to see the full list of 230 stocks from our US High Growth Tech and AI Stocks screener.

We're going to check out a few of the best picks from our screener tool.

AbbVie

Simply Wall St Growth Rating: ★★★★☆☆

Overview: AbbVie Inc. is a research-based biopharmaceutical company focused on the development, manufacture, and sale of medicines and therapies globally, with a market capitalization of approximately $328.75 billion.

Operations: AbbVie generates revenue primarily from its Innovative Medicines and Therapies segment, which accounts for $57.37 billion. The company is involved in the research, development, manufacture, and sale of biopharmaceutical products worldwide.

AbbVie's strategic alliance with the Sarah Cannon Research Institute, announced on May 28, 2025, underscores its commitment to accelerating cancer therapy innovations. This collaboration is expected to enhance clinical trial delivery and drug development efficiency through SCRI's advanced research capabilities. Concurrently, AbbVie's recent FDA approval of EMRELIS™ for specific lung cancer patients highlights its ongoing focus on addressing critical medical needs through targeted therapies. These developments reflect AbbVie’s robust investment in R&D which is integral to advancing its pipeline and maintaining competitive advantage in biotech innovation.

• Get an in-depth perspective on AbbVie's performance by reading our health report here.

• Explore historical data to track AbbVie's performance over time in our Past section.

Fair Isaac

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Fair Isaac Corporation is a company that specializes in developing software with analytics and digital decisioning technologies for global markets, with a market cap of $42.02 billion.

Operations: Fair Isaac Corporation generates revenue primarily through its Scores segment, contributing $1.02 billion, and Software segment, which adds $817 million.

Fair Isaac Corporation (FICO) is demonstrating robust growth in the tech sector, particularly through its innovative AI solutions that enhance client operations. Recently, FICO has been pivotal for Vitality's Care Hub, revolutionizing healthcare management by integrating digital pathways that reduce operational costs and improve claims processing efficiency. This collaboration underscores FICO's commitment to leveraging technology for transformative business solutions. Financially, FICO is on a strong trajectory with a 13.1% annual revenue growth and an 18% earnings growth forecast, outpacing the US market averages of 8.6% and 14.4%, respectively. Additionally, their strategic use of R&D investment enhances their competitive edge in the high-stakes tech landscape.

• Dive into the specifics of Fair Isaac here with our thorough health report.

• Gain insights into Fair Isaac's past trends and performance with our Past report.

Oracle

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Oracle Corporation provides a range of products and services for enterprise IT environments globally, with a market capitalization of approximately $464.18 billion.

Operations: Oracle generates revenue primarily from three segments: Cloud and License ($47.60 billion), Services ($5.26 billion), and Hardware ($2.93 billion). The company's business model focuses on providing comprehensive IT solutions, with a significant portion of its income derived from cloud services and software licensing.

Oracle's strategic initiatives in AI and cloud solutions are reshaping its market presence, particularly through its recent partnerships and client engagements. The company's involvement in the Stargate UAE project alongside global tech leaders underscores its commitment to pioneering next-generation AI infrastructures, which is poised to enhance capabilities across various sectors including healthcare and finance. This collaboration not only expands Oracle’s technological footprint but also aligns with broader economic development goals by fostering innovation. Moreover, Oracle’s R&D investments remain robust, as evidenced by a consistent allocation of resources towards developing cutting-edge technologies. For instance, the company has strategically increased its R&D expenditure to $6.5 billion in 2024 from $6.1 billion the previous year, reflecting a growth of approximately 6.56%. This investment fuels advancements in Oracle's cloud services and software solutions, ensuring that it stays at the forefront of technological innovation and continues to offer competitive services to its clients like Lyntia Networks, enhancing their operational efficiencies through advanced OSS solutions powered by Oracle Communications Cloud Native Suite.

• Unlock comprehensive insights into our analysis of Oracle stock in this health report.

• Learn about Oracle's historical performance.

Turning Ideas Into Actions

• Unlock our comprehensive list of 230 US High Growth Tech and AI Stocks by clicking here.
• Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
• Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.

Want To Explore Some Alternatives?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NYSE:ABBV NYSE:FICO and NYSE:ORCL.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com